TNDM beat EPS expectations by 89.63%
Feb 19, 2026, 11:35 PM
0.00%
What does TNDM do
Tandem Diabetes Care, based in San Diego, focuses on products for insulin-dependent diabetes, employing 2,400 staff since its IPO in 2013. Its advanced insulin pumps, including the t:slim X2, feature Control-IQ technology and are compatible with various CGM sensors.
Tandem Diabetes Care (TNDM) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Tandem Diabetes Care's actual EPS was -$0.01, beating the estimate of -$0.10 per share, resulting in a 89.63% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.